Literature DB >> 24817672

The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.

Rebecca Klein1, Stefan Blaschke, Bernd Neumaier, Heike Endepols, Rudolf Graf, Meike Keuters, Joerg Hucklenbroich, Morten Albrechtsen, Stephen Rees, Gereon Rudolf Fink, Michael Schroeter, Maria Adele Rueger.   

Abstract

The neural cell adhesion molecule (NCAM) plays a role in neurite outgrowth, synaptogenesis, and neuronal differentiation. The NCAM mimetic peptide FG Loop (FGL) promotes neuronal survival in vitro and enhances spatial learning and memory in rats. We here investigated the effects of FGL on neural stem cells (NSC) in vitro and in vivo. In vitro, cell proliferation of primary NSC was assessed after exposure to various concentrations of NCAM or FGL. The differentiation potential of NCAM- or FGL-treated cells was assessed immunocytochemically. To investigate its influence on endogenous NSC in vivo, FGL was injected subcutaneously into adult rats. The effects on NSC mobilization were studied both via non-invasive positron emission tomography (PET) imaging using the tracer [(18)F]-fluoro-L-thymidine ([(18)F]FLT), as well as with immunohistochemistry. Only FGL significantly enhanced NSC proliferation in vitro, with a maximal effect at 10 μg/ml. During differentiation, NCAM promoted neurogenesis, while FGL induced an oligodendroglial phenotype; astrocytic differentiation was neither affected by NCAM or FGL. Those differential effects of NCAM and FGL on differentiation were mediated through different receptors. After FGL-injection in vivo, proliferative activity of NSC in the subventricular zone (SVZ) was increased (compared to placebo-treated animals). Moreover, non-invasive imaging of cell proliferation using [(18)F]FLT-PET supported an FGL-induced mobilization of NSC from both the SVZ and the hippocampus. We conclude that FGL robustly induces NSC mobilization in vitro and in vivo, and supports oligodendroglial differentiation. This capacity renders FGL a promising agent to facilitate remyelinization, which may eventually make FGL a drug candidate for demyelinating neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24817672     DOI: 10.1007/s12015-014-9512-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  40 in total

1.  In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord.

Authors:  David J Martens; Raewyn M Seaberg; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2002-09       Impact factor: 3.386

2.  A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo.

Authors:  Galina G Skibo; Iryna V Lushnikova; Kyrill Y Voronin; Oksana Dmitrieva; Tatiana Novikova; Boris Klementiev; Elisabetta Vaudano; Vladimir A Berezin; Elisabeth Bock
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

3.  Imaging-guided gene therapy of experimental gliomas.

Authors:  Andreas H Jacobs; Maria Adele Rueger; Alexandra Winkeler; Hongfeng Li; Stefan Vollmar; Yannic Waerzeggers; Benedikt Rueckriem; Christiane Kummer; Claus Dittmar; Markus Klein; Michael T Heneka; Ulrich Herrlinger; Cornel Fraefel; Rudolf Graf; Klaus Wienhard; Wolf-Dieter Heiss
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

4.  Effects of minocycline on endogenous neural stem cells after experimental stroke.

Authors:  M A Rueger; S Muesken; M Walberer; S U Jantzen; K Schnakenburg; H Backes; R Graf; B Neumaier; M Hoehn; G R Fink; M Schroeter
Journal:  Neuroscience       Date:  2012-04-24       Impact factor: 3.590

5.  Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors.

Authors:  Dragan Maric; Alessandra Fiorio Pla; Yoong Hee Chang; Jeffery L Barker
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

6.  A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation.

Authors:  Karine Cambon; Stine M Hansen; Cesar Venero; A Isabel Herrero; Galina Skibo; Vladimir Berezin; Elisabeth Bock; Carmen Sandi
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

Review 7.  The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system.

Authors:  L C Rønn; B P Hartz; E Bock
Journal:  Exp Gerontol       Date:  1998 Nov-Dec       Impact factor: 4.032

8.  A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke.

Authors:  Justine J Overman; Andrew N Clarkson; Ina B Wanner; William T Overman; Ilya Eckstein; Jaime L Maguire; Ivo D Dinov; Arthur W Toga; S Thomas Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-25       Impact factor: 11.205

9.  Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.

Authors:  J Liu; K Solway; R O Messing; F R Sharp
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat.

Authors:  Takashi Amemori; Nataliya Romanyuk; Pavla Jendelova; Vit Herynek; Karolina Turnovcova; Pavel Prochazka; Miroslava Kapcalova; Graham Cocks; Jack Price; Eva Sykova
Journal:  Stem Cell Res Ther       Date:  2013-06-07       Impact factor: 6.832

View more
  10 in total

1.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

Review 2.  In vivo imaging of endogenous neural stem cells in the adult brain.

Authors:  Maria Adele Rueger; Michael Schroeter
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 3.  The macrosphere model-an embolic stroke model for studying the pathophysiology of focal cerebral ischemia in a translational approach.

Authors:  Maureen Walberer; Maria Adele Rueger
Journal:  Ann Transl Med       Date:  2015-06

4.  Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.

Authors:  Anne Ladwig; Rebecca Rogall; Jörg Hucklenbroich; Antje Willuweit; Michael Schoeneck; Karl-Josef Langen; Gereon R Fink; M Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-28       Impact factor: 4.147

Review 5.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

6.  Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4.

Authors:  Monika Rabenstein; Joerg Hucklenbroich; Antje Willuweit; Anne Ladwig; Gereon Rudolf Fink; Michael Schroeter; Karl-Josef Langen; Maria Adele Rueger
Journal:  Stem Cell Res Ther       Date:  2015-05-22       Impact factor: 6.832

7.  Bioluminescence imaging visualizes osteopontin-induced neurogenesis and neuroblast migration in the mouse brain after stroke.

Authors:  Rebecca Rogall; Monika Rabenstein; Sabine Vay; Annika Bach; Anton Pikhovych; Johannes Baermann; Mathias Hoehn; Sébastien Couillard-Despres; Gereon Rudolf Fink; Michael Schroeter; Maria Adele Rueger
Journal:  Stem Cell Res Ther       Date:  2018-07-04       Impact factor: 6.832

8.  NCAM regulates temporal specification of neural progenitor cells via profilin2 during corticogenesis.

Authors:  Rui Huang; De-Juan Yuan; Shao Li; Xue-Song Liang; Yue Gao; Xiao-Yan Lan; Hua-Min Qin; Yu-Fang Ma; Guang-Yin Xu; Melitta Schachner; Vladimir Sytnyk; Johannes Boltze; Quan-Hong Ma; Shen Li
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

9.  Transcranial Current Stimulation Alters the Expression of Immune-Mediating Genes.

Authors:  Monika Rabenstein; Marcus Unverricht-Yeboah; Meike Hedwig Keuters; Anton Pikhovych; Joerg Hucklenbroich; Sabine Ulrike Vay; Stefan Blaschke; Anne Ladwig; Helene Luise Walter; Magdalena Beiderbeck; Gereon Rudolf Fink; Michael Schroeter; Ralf Kriehuber; Maria Adele Rueger
Journal:  Front Cell Neurosci       Date:  2019-10-25       Impact factor: 5.505

Review 10.  Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer's Disease.

Authors:  Chuan Qin; Yongning Li; Kewei Wang
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.